ID   A904-EBV-B
AC   CVCL_A5AL
DR   Wikidata; Q107113338
RX   PubMed=15994973;
RX   PubMed=17131342;
CC   Population: Chinese; Han and Korean.
CC   HLA typing: A*24:02,26:03; B*07:02,39:01; C*07:02 (PubMed=15994973).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U095 ! A904L
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 6
//
RX   PubMed=15994973; DOI=10.1158/0008-5472.CAN-04-3787;
RA   So T., Takenoyama M., Mizukami M., Ichiki Y., Sugaya M., Hanagiri T.,
RA   Sugio K., Yasumoto K.;
RT   "Haplotype loss of HLA class I antigen as an escape mechanism from
RT   immune attack in lung cancer.";
RL   Cancer Res. 65:5945-5952(2005).
//
RX   PubMed=17131342; DOI=10.1002/ijc.22396;
RA   Sugaya M., Takenoyama M., Shigematsu Y., Baba T., Fukuyama T.,
RA   Nagata Y., Mizukami M., So T., Ichiki Y., Yasuda M., So T.,
RA   Hanagiri T., Sugio K., Yasumoto K.;
RT   "Identification of HLA-A24 restricted shared antigen recognized by
RT   autologous cytotoxic T lymphocytes from a patient with large cell
RT   carcinoma of the lung.";
RL   Int. J. Cancer 120:1055-1062(2007).
//